JG
JSPR icon

Jain Global’s Jasper Therapeutics JSPR Stock Holding History

Jain Global’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.5K Buy
51,185
+33,163
+184% +$24.8K ﹤0.01% 1703
2026
Q1 		$15.8K Sell
18,022
-25,279
-58% -$35.1K ﹤0.01% 1155
2025
Q4 		$79.2K Buy
+43,301
New +$86.9K ﹤0.01% 1126
2025
Q3 		– Sell
-12,130
Closed -$67.3K – 1276
2025
Q2 		$67.3K Buy
+12,130
New +$59.7K ﹤0.01% 1071

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's JSPR Position: Q2 2026 in Review

Jain Global increased its Jasper Therapeutics (JSPR) stake by 184% in Q2 2026, buying an estimated $24.8K and bringing the position to 51,185 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1703.

Jain Global first reported a position in JSPR in Q2 2025 and has held it in 4 quarters since. The position peaked at $79.2K in Q4 2025. 45 funds tracked by Wall St. Rank hold JSPR as of Q2 2026.

  • Jain Global held 51,185 shares of Jasper Therapeutics worth $21.5K as of Q2 2026.
  • Jain Global bought 33,163 Jasper Therapeutics shares in Q2 2026, an estimated $24.8K.
  • Jasper Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1703 holding.
  • Jain Global first reported a position in Jasper Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Jain Global's Jasper Therapeutics position peaked at $79.2K in Q4 2025.
  • 45 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.